Pune, India -- (SBWire) -- 08/29/2018 --Market Analysis: Global Cancer Biomarkers Market
The Global Cancer Biomarkers Market has accounted to USD 10.9 billion in 2016, growing at a CAGR of 12.2% from 2017 to 2024, and is expected to reach USD 27.4 billion by 2024.
For In depth Information Get Free Sample Copy of this Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-biomarkers-market
Market Definition: Global Cancer Biomarkers Market
Cancer biomarkers are the molecules secreted by a tumor or a specific response of the human body indicating the presence of cancer. The biomarkers enable cancer detection at an early stage and facilitate high-speed noninvasive diagnosis using various genomics and proteomics tools. Cancer biomarkers are used for various applications such as cancer diagnostics, drug discovery and development, prognostics, personalized medicine, and surrogate endpoints. Over the years, cancer biomarkers have become an integral part of research in pharmaceutical and clinical trial companies, as they help to reduce the time and cost of the drug discovery and development process.
Factors such as rising prevalence of cancer, increasing government support for cancer biomarkers research, rising aging population, increasing use of biomarkers in the drug discovery and development process, and increasing use of biomarker tests for diagnosis purposes are fueling the growth of this market. However, poorly suited regulatory and reimbursement systems and high capital investments required for biomarker development and validation are the major factors restraining the growth of this market. Cancer biomarkers' research and development is highly capital intensive; this is one of the key entry barriers for new players willing to enter the cancer biomarkers market. Majority of the biomarker development studies receive funding from government organizations or large pharmaceutical companies.
Market Segmentation: Global Cancer Biomarkers Market
Based on type:
- Protein Biomarkers
- Genetic Biomarkers
- Other Biomarkers (Includes Viral, Cell, And Carbohydrate Biomarkers)
Based on cancer type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Other Cancers (Includes Melanoma, Leukemia, Gastric, Kidney, Liver, And Pancreatic Cancers).
By profiling technology:
- Omics Technologies
- Imaging Technologies
- Immunoassays
- Cytogenetics
- Bioinformatics
By Application:
- Diagnostic
- Drug Discovery
- Prognostic
Based on geography:
- North America
- Europe
- Asia-Pacific
- South America
- Rest Of The World
Request for Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-cancer-biomarkers-market
Major Market Competitors: Global Cancer Biomarkers Market
- Abbott Laboratories
- DiagnoCure Inc.
- Affymetrix, Inc.
- Illumina, Inc.
- Qiagen N.V.
- Roche Diagnostics Ltd.
- Agilent Technologies Inc.
- Quest Diagnostics Inc.
- Merck & Co. Inc.
- Hologic, Inc.
- Becton Dickinson and Company
- Among others.
Order a Copy of Global Cancer Biomarkers Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-biomarkers-market
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Cancer Biomarkers Market - Global Industry Insights, Trends, Outlook, Opportunity Analysis, Key Manufacturers, 2018-2024
The report provides a comprehensive analysis of the Cancer Biomarkers Market by Tumor, type, applications, profiling technology, players and regions. This report also displays the 2017-2024 production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR and Market influencing factors of the Cancer Biomarkers industry in North America, Europe, Asia-Pacific, South America, Rest of the World.